27 related articles for article (PubMed ID: 8929710)
1. Definition of HLA-DQ as a transplantation antigen.
Petersdorf EW; Longton GM; Anasetti C; Mickelson EM; Smith AG; Martin PJ; Hansen JA
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15358-63. PubMed ID: 8986816
[TBL] [Abstract][Full Text] [Related]
2. HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation.
Petersdorf EW; Stevenson P; Bengtsson M; De Santis D; Dubois V; Gooley T; Horowitz M; Hsu K; Madrigal JA; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Carrington M
Blood; 2020 Jul; 136(3):362-369. PubMed ID: 32483623
[TBL] [Abstract][Full Text] [Related]
3. High HLA-DP Expression and Graft-versus-Host Disease.
Petersdorf EW; Malkki M; O'hUigin C; Carrington M; Gooley T; Haagenson MD; Horowitz MM; Spellman SR; Wang T; Stevenson P
N Engl J Med; 2015 Aug; 373(7):599-609. PubMed ID: 26267621
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte Crossmatch Testing or Donor HLA-DP and -DQ Allele Typing Effectiveness in Single Cord Blood Transplantation for Patients With Anti-HLA Antibodies Other Than Against HLA-A, -B, -C, and -DRB1.
Osada M; Yamamoto H; Watanabe O; Yamaguchi K; Kageyama K; Kaji D; Taya Y; Nishida A; Ishiwata K; Takagi S; Makino S; Asano-Mori Y; Yamamoto G; Taniguchi S; Wake A; Uchida N
Transplant Cell Ther; 2024 Apr; ():. PubMed ID: 38641011
[TBL] [Abstract][Full Text] [Related]
5. A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation.
Espinoza JL; Takami A; Nakata K; Onizuka M; Kawase T; Akiyama H; Miyamura K; Morishima Y; Fukuda T; Kodera Y; Nakao S;
PLoS One; 2011; 6(10):e26229. PubMed ID: 22028838
[TBL] [Abstract][Full Text] [Related]
6. Race, Ethnicity and Ancestry in Unrelated Transplant Matching for the National Marrow Donor Program: A Comparison of Multiple Forms of Self-Identification with Genetics.
Hollenbach JA; Saperstein A; Albrecht M; Vierra-Green C; Parham P; Norman PJ; Maiers M
PLoS One; 2015; 10(8):e0135960. PubMed ID: 26287376
[TBL] [Abstract][Full Text] [Related]
7. Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitro.
Gervais A; Eymard JC; Toulmonde E; Bernard J
Cancer Immunol Immunother; 2009 Nov; 58(11):1831-41. PubMed ID: 19330330
[TBL] [Abstract][Full Text] [Related]
8. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors.
Anasetti C; Hansen JA
Transfus Sci; 1994 Sep; 15(3):221-30. PubMed ID: 10155543
[TBL] [Abstract][Full Text] [Related]
9. Effect of HLA mismatch on acute graft-versus-host disease.
Kanda J
Int J Hematol; 2013 Sep; 98(3):300-8. PubMed ID: 23893313
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation.
Mickelson EM; Longton G; Anasetti C; Petersdorf E; Martin P; Guthrie LA; Hansen JA
Tissue Antigens; 1996 Jan; 47(1):27-36. PubMed ID: 8929710
[TBL] [Abstract][Full Text] [Related]
11. Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors.
Mickelson EM; Guthrie LA; Etzioni R; Anasetti C; Martin PJ; Hansen JA
Tissue Antigens; 1994 Aug; 44(2):83-92. PubMed ID: 7817382
[TBL] [Abstract][Full Text] [Related]
12. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
Petersdorf EW; Kollman C; Hurley CK; Dupont B; Nademanee A; Begovich AB; Weisdorf D; McGlave P
Blood; 2001 Nov; 98(10):2922-9. PubMed ID: 11698272
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri IF; Folloder J; Ueno NT; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson BS; Champlin R
Biol Blood Marrow Transplant; 2000; 6(2A):190-7. PubMed ID: 10816027
[TBL] [Abstract][Full Text] [Related]
14. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation.
Petersdorf EW; Longton GM; Anasetti C; Martin PJ; Mickelson EM; Smith AG; Hansen JA
Blood; 1995 Aug; 86(4):1606-13. PubMed ID: 7632970
[TBL] [Abstract][Full Text] [Related]
15. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
